868 related articles for article (PubMed ID: 26021314)
21. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.
Sagar S; Leiphrakpam PD; Thomas D; McAndrews KL; Caffrey TC; Swanson BJ; Clausen H; Wandall HH; Hollingsworth MA; Radhakrishnan P
Cancer Lett; 2021 Apr; 503():91-102. PubMed ID: 33485947
[TBL] [Abstract][Full Text] [Related]
22. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
[TBL] [Abstract][Full Text] [Related]
24. Cosmc overexpression enhances malignancies in human colon cancer.
Gao T; Du T; Hu X; Dong X; Li L; Wang Y; Liu J; Liu L; Gu T; Wen T
J Cell Mol Med; 2020 Jan; 24(1):362-370. PubMed ID: 31633299
[TBL] [Abstract][Full Text] [Related]
25. Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer.
Thomas D; Sagar S; Liu X; Lee HR; Grunkemeyer JA; Grandgenett PM; Caffrey T; O'Connell KA; Swanson B; Marcos-Silva L; Steentoft C; Wandall HH; Maurer HC; Peng XL; Yeh JJ; Qiu F; Yu F; Madiyalakan R; Olive KP; Mandel U; Clausen H; Hollingsworth MA; Radhakrishnan P
Mol Ther; 2021 Apr; 29(4):1557-1571. PubMed ID: 33359791
[TBL] [Abstract][Full Text] [Related]
26. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
27. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.
Sutherlin ME; Nishimori I; Caffrey T; Bennett EP; Hassan H; Mandel U; Mack D; Iwamura T; Clausen H; Hollingsworth MA
Cancer Res; 1997 Nov; 57(21):4744-8. PubMed ID: 9354435
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
[TBL] [Abstract][Full Text] [Related]
29. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
[TBL] [Abstract][Full Text] [Related]
30. Cosmc is an essential chaperone for correct protein O-glycosylation.
Wang Y; Ju T; Ding X; Xia B; Wang W; Xia L; He M; Cummings RD
Proc Natl Acad Sci U S A; 2010 May; 107(20):9228-33. PubMed ID: 20439703
[TBL] [Abstract][Full Text] [Related]
31. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
[TBL] [Abstract][Full Text] [Related]
32. Truncated O-GalNAc glycans impact on fundamental signaling pathways in pancreatic cancer.
Hofmann BT; Picksak AS; Kwiatkowski M; Grupp K; Jücker M; Bachmann K; Mercanoglu B; Izbicki JR; Kahlert C; Bockhorn M; Güngör C; Ewald F; Wolters-Eisfeld G
Glycobiology; 2021 Aug; ():. PubMed ID: 34420045
[TBL] [Abstract][Full Text] [Related]
33. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
[TBL] [Abstract][Full Text] [Related]
34. Cosmc-dependent mucin-type
Stotter BR; Talbot BE; Capen DE; Artelt N; Zeng J; Matsumoto Y; Endlich N; Cummings RD; Schlondorff JS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F518-F530. PubMed ID: 31904283
[TBL] [Abstract][Full Text] [Related]
35. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
36. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
37. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
38. The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
Ho CW; Lin CY; Liaw YW; Chiang HL; Chin YT; Huang RL; Lai HC; Hsu YW; Kuo PJ; Chen CE; Lin HY; Whang-Peng J; Nieh S; Fu E; Liu LF; Hwang J
Oncotarget; 2016 Sep; 7(38):61930-61944. PubMed ID: 27542280
[TBL] [Abstract][Full Text] [Related]
39. CD3/CD28 dynabeads induce expression of tn antigen in human t cells accompanied by hypermethylation of the cosmc promoter.
Shi C; Xu X; Yu X; Du Z; Luan X; Liu D; Hu T
Mol Immunol; 2017 Oct; 90():98-105. PubMed ID: 28708980
[TBL] [Abstract][Full Text] [Related]
40. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
